This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Gil Price, MD
ClinTrials Research Raleigh, NC

JAMA. 1995;274(16):1267-1268.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—As a physician previously responsible for pharmaceutical sales training, I would like to respond to the article by Dr Ziegler and colleagues¹ on the accuracy of sales information. My former company (Glaxo Wellcome Inc) strongly supports the position enunciated by Orlowski and Wateska.² Patients have a right to expect that a service or product is recommended or prescribed because it is needed and because it is the most efficacious, the safest, and the most cost-effective, based on sound professional judgment. Glaxo has made a major effort to ensure that its representatives are trained to the highest professional standards to impart accurately and comprehensively the medical and technical knowledge that physicians require to use the company's products in their patients' best interests.

With the development of new, more effective medicines with novel modes of action, company representatives have an important role in educating physicians in all . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?